Clinical Trial Update: A Pilot Study of the Grapefruit Flavonoid Naringenin for HCV Infection [Phase 1]

View source ↗

Summary

A Phase 1 pilot study evaluating the grapefruit flavonoid naringenin for hepatitis C virus infection has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Naringenin (naringenin)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Hepatitis C Virus, HCV Infection | Phase 1 | Status: COMPLETED